NIAID is committed to the research necessary to successfully end HIV/AIDS. Each year, 50,000 people in the United States become infected with HIV, the virus that causes AIDS. Currently, there are an estimated 1.1 million people in the United States and 34 million people globally who are living with HIV infection. In 2011, 1.7 million people died from AIDS-related causes. Through our laboratories and clinics at the National Institutes of Health to our vast network of supported research at universities, medical centers, and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection, develop new and more effective treatments for HIV-infected people, and find a cure.
Media Availability: HIV Controls Its Activity Independent of Host Cells—Feb. 26, 2015
NIH-Sponsored HIV Vaccine Trial Launches in South Africa—Feb. 18, 2015
NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic—Feb. 18, 2015
NIH-Supported Clinical Trials to Evaluate Long-Acting, Injectable Antiretroviral Drugs to Prevent HIV Infection—Feb. 18, 2015
News From NIAID-Supported Institutions
Browse illustrations and multimedia describing the basics of HIV/AIDS, clinical research that is underway, and scientific advances.
Last Updated February 26, 2015